Russia's Sputnik V Vaccine Developer Hopes to Receive WHO Approval Before 2022

NOVOSIBIRSK (Sputnik) – The developer of the Russian Sputnik V COVID-19 vaccine, Gamaleya research institute, hopes that the drug will receive necessary approval from the World Health Organization (WHO) by the end of the year, Vladimir Gushchin, a senior researcher at the institute, said on Tuesday.